Dr. Gregg Goldin (Co-Chief Resident, PGY 4)

 

Gregg Goldin

Gregg Goldin, MD

Education

  • Undergraduate:  University of Florida, Gainesville, FL
  • Medical School: University of Miami Miller School of Medicine, Miami, FL
  • Internship: University of Florida Shands Hospital, Jacksonville, FL

 

      Honors and Awards

      Residency:

      • Recipient of an ASTRO Travel Award to attend the 2013 ASTRO Advocacy Day, Washington, DC, April 29-30, 2013

       

        Research Interests

        SEER-Medicare population studies; comparative morbidity for prostate cancer; functional imaging and radiation toxicity

         

        Publications

        (as of 5/15/13)

        • Goldin G.  Clinical outcomes of CyberKnife® radiosurgery for early stage lung cancer: low chest wall toxicity rates associated with tracking. (Abstract.)  Radiological Society of North American Annual Meeting, Chicago, IL, December, 2012. (Poster presentation.)
        • Goldin G, Marks L, Morris, D.  Clinical outcomes of Cyberknife radiosurgery for early stage lung cancer: low chest wall toxicity rates associated with tracking. (Abstract.) Annual Multidisciplinary Symposium in Thoracic Oncology, Chicago, IL, September, 2012. (Poster presentation.)
        • Sheets NC, Goldin GH, Meyer AM, Wu Y, Chang Y, Stürmer T, Holmes JA, Reeve BB, Godley PA, Carpenter WR, Chen RC.  Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.  JAMA 307(15):1611-1620, 2012.
        • Goldin, G, Sheets NC, Chen RC.  Patterns of intensity modulated radiation therapy (IMRT) use for the definitive and post-operative treatments of prostate cancer, a SEER-Medicare analysis. (Abstract.) American Society for Radiation Oncology Annual Meeting, Miami, FL, October, 2011. (Poster presentation.)
        • Sheets  NC, Goldin G, Chen RC.  Comparative long-term morbidity of intensity-modulated versus conformal radiation therapy (RT) for prostate cancer, a SEER-Medicare analysis.  (Abstract.)  American Society for Radiation Oncology Annual Meeting, Miami, FL, October, 2011. (Oral presentation.)
        • Goldin G, Vargas C, Bridges M. Magnetic resonance spectroscopy and definition of cancer rich targets in the prostate. (Abstract.)  American Society for Therapeutic Radiology and Oncology Annual Meeting, Boston, MA, September, 2008. (Poster presentation.)